Incident heart failure and myocardial infarction in sodium-glucose cotransporter 2 versus dipeptidyl peptidase-4 inhibitor users,medRxiv - Cardiovascular Medicine

当前位置： X-MOL 学术 › medRxiv. Cardiovasc. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Incident heart failure and myocardial infarction in sodium-glucose cotransporter 2 versus dipeptidyl peptidase-4 inhibitor users
medRxiv - Cardiovascular Medicine Pub Date : 2021-11-21 , DOI: 10.1101/2021.11.21.21266648
Jiandong Zhou , Sharen Lee , Keith Sai Kit Leung , Abraham Ka Chung Wai , Tong Liu , Ying Liu , Dong Chang , Wing Tak Wong , Ian C.K. Wong , Bernard Man Yung Cheung , Qingpeng Zhang , Gary Tse

Objectives To compare the rates of major cardiovascular adverse events in sodium-glucose cotransporter-2 inhibitors (SGLT2I) and dipeptidyl-peptidase-4 inhibitors (DPP4I) users in a Chinese population.

更新日期：2021-11-25

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文